One team demonstrated that NOX4 improved I/R outcome: in transgenic mice subjected to I/R, cardiac-specific overexpression of NOX4 preserved LV systolic function and increased macrophages proportion and polarization toward an M2 phenotype, resulting in improved post-MI survival, remodeling and healing [74] (Table 1). The gene discussed is NOX4; the disease is myocardial infarction.